Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease.
Seidel C, Hjertner Ø, Abildgaard N, Heickendorff L, Hjorth M, Westin J, Nielsen JL, Hjorth-Hansen H, Waage A, Sundan A, Børset M; Nordic Myeloma Study Group.
Seidel C, et al. Among authors: heickendorff l.
Blood. 2001 Oct 1;98(7):2269-71. doi: 10.1182/blood.v98.7.2269.
Blood. 2001.
PMID: 11568016
Free article.